Evidence map›Paper›PMID 35320338›Full record

ArticleBlood advances2022

Deferasirox-induced robust and dose-dependent reversal of anemia in a patient with variants in the TRIB2 and ABCB6 genes.

Julia Stomper, Paulina Richter-Pechanska, Dietmar Pfeifer, Immacolata Andolfo, Achille Iolascon, Martina U Muckenthaler, Michael Lübbert

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Julia StomperDepartment of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.ORCID 0000-0002-3858-4385
Paulina Richter-PechanskaDepartment of Pediatric Oncology, Hematology and Immunology, University of Heidelberg and Hopp Children's Cancer Center at NCT, Heidelberg, Germany.
Dietmar PfeiferDepartment of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Immacolata AndolfoDipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli 'Federico II', Napoli, Italy; and.
Achille IolasconDipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli 'Federico II', Napoli, Italy; and.
Martina U MuckenthalerDepartment of Pediatric Oncology, Hematology and Immunology, University of Heidelberg and Hopp Children's Cancer Center at NCT, Heidelberg, Germany.
Michael LübbertDepartment of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.ORCID 0000-0003-1186-1650

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnemiaATP-Binding Cassette TransportersCalcium-Calmodulin-Dependent Protein KinasesDeferasiroxHumansIron Chelating AgentsABCB6 protein, humanATP-Binding Cassette TransportersCalcium-Calmodulin-Dependent Protein KinasesDeferasiroxIron Chelating AgentsTRIB2 protein, human

Identifiers

PMID35320338
PMCPMC9198926

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.